ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

Evaluation of Tonabersat for DME

ClinicalTrials.gov ID: NCT05727891

Public ClinicalTrials.gov record NCT05727891. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Evaluation of Tonabersat for Diabetic Macular Edema (Protocol AN)

Study identification

NCT ID
NCT05727891
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Jaeb Center for Health Research
Other
Enrollment
128 participants

Conditions and interventions

Interventions

  • Placebo Other
  • Tonabersat Drug

Other · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 1, 2023
Primary completion
Jun 26, 2025
Completion
Dec 31, 2025
Last update posted
Dec 10, 2025

2023 – 2026

United States locations

U.S. sites
28
U.S. states
15
U.S. cities
26
Facility City State ZIP Site status
Retina Associates of Southern California Huntington Beach California 92647
Loma Linda University Loma Linda California 92354
East Bay Retina Consultants, Inc. Oakland California 94609
Southern California Desert Retina Consultants, Inc. Palm Desert California 92211
Macula Retina Vitreous Institute Torrance California 90503
National Ophthalmic Research Institute Fort Myers Florida 33912
University of Florida- Jacksonville Jacksonville Florida 32209
Central Florida Retina Institute Lakeland Florida 33805
Florida Retina Consultants Lakeland Florida 33805
Southeast Eye Institute, P.A. dba Eye Associates of Pinellas Pinellas Park Florida 33782
Southeast Retina Center Augusta Georgia 30909
Thomas Eye Group Sandy Springs Georgia 30328
Illinois Retina Associates Oak Park Illinois 60304
Midwest Eye Institute Indianapolis Indiana 46290
Joseph E. Humble and Raymond Haik PTRS DBA Eye Assoc of Northeast Louisiana West Monroe Louisiana 71291
Elman Retina Group Baltimore Maryland 21237
Boston Medical Center Corporation Boston Massachusetts 02118
Joslin Diabetes Center Boston Massachusetts 02215
Mayo Clinic Rochester Minnesota 55905
Retina Research Institute, LLC St Louis Missouri 63128
Retina-Vitreous Surgeons of Central NY, PC Liverpool New York 13088
Verum Research LLC Eugene Oregon 97401
The Trustees of the University of Pennsylvania Philadelphia Pennsylvania 19104
Pittsburg Clinical Trial Consortium Sewickley Pennsylvania 15143
Hilton Head Retina Institute Hilton Head Island South Carolina 29926
Retina Consultants of Texas, PA Bellaire Texas 77401
Texas Retina Associates Lubbock Texas 79424
Retinal Consultants of Texas San Antonio Texas 78240

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05727891, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 10, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05727891 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →